Home » Health and medicine » Living medicines » News Digest #248 – Twist’s IPO, IndieBio’s demo day, Synlogic’s new data and Ginkgo’s de-extinct scent.

News Digest #248 – Twist’s IPO, IndieBio’s demo day, Synlogic’s new data and Ginkgo’s de-extinct scent.


SynBioBeta Digest

Your guide to what’s new in synthetic biology

Hi all,

Twist’s IPO last week has the company up more than 10% from its opening price of $14, valuing the company at $421M.

Demand is rising for a well-trained generation of synthetic biologists to help industry meet government targets and sustainable development goals. This week, learn how leaders in the UK are training future generations of synthetic biologists.

IndieBio’s Demo Day was yesterday, with 13 companies presenting on a range of new and cool bio companies ready to hit the market.

Visolis is finalizing the acquisition of its first production plant, located in Ontario, Canada. Originally built to produce succinate — ”a bio building block”  — Visolis CEO Deepak Dugar says that by early 2019, he expects the plant will be producing a range of sustainable, carbon-negative materials.

In living medicines, Synlogic presented preliminary data from its first Synthetic Biotic(™) Clinical Candidate. The data highlight the advantages of Synlogic’s unique synthetic biotic approach to activate the local innate immune system for the potential treatment of solid tumors.

Finally, in resurrection news, Ginkgo Bioworks has succeeded in reviving the smell of an extinct flower by expressing the genes needed for making its pungent aroma molecules in microbes. Want to know what a Hawaiian hibiscus flower that vanished from the dry-land forests of Maui in the early 1910s smells like? Read this article.

Have a great week!


Latest news

Which biological systems should be engineered?

Read more →

Editing nature: a call for careful oversight of environmental gene editing

Read more →

Breakout Labs’ Unboxing shines light on deep technologies

Read more →

The University of Bristol partners with the Max Planck Society to establish a Centre for Minimal Biology

Read more →

C&EN’s 2018 10 start-ups to watch

Read more →

Storing digital data in synthetic DNA with Dr. Karin Strauss

Read more →

Thanks to our sponsors:

Thermo Fisher Scientific


Mintz Levin

More reads

More reads

How biologists are creating life-like cells from scratch (Nature News)

Elemental Machines announces Element-D, the newest addition to its platform for data analytics (Press release)

Cyrus Biotechnology and OpenEye Scientific Software to expedite new drug design and development with Cyrus Bench Platform (Press release)

Unibio enters into an agreement with PETRONAS Chemicals Group Berhad to conduct product trials of Uniprotein® (Press release)

Ugandan scientists poised to release vitamin-fortified GMO banana (Genetic Literacy)

RebelBio is looking for science graduates, PhDs, postdocs and academics who want to commercialize their research – Apply by Dec. 1st

Vedanta Biosciences announces preclinical data on microbiome-derived immuno-oncology candidate (Press release)

ERS Genomics licenses CRISPR gene editing technology to DefiniGEN, to support the preclinical development of therapeutics (Press release)

Biome Bioplastics launches plastic educational channel

Who's hiring?

Who’s hiring?

Research Associate II/Senior Research Associate – Strain Analytics: Pivot Bio, Berkeley, CA

Junior Strategist @ BWK

Microbial Formulation Process Development Senior Scientist: Pivot Bio, Berkeley, CA

ARPA-E Program Director in Synthetic Biology

Head of Operations – Ginkgo Bioworks, Boston, MA

Data Quality Research Associate: Pivot Bio, Berkeley, CA

Senior Software Engineer (Synthetic Biology Automation), Edinburgh Genome Foundry

Feature your job here →


Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks